BAKIR EKİNCİ, P. Et Al. 2023. Initial Empirical Antibiotic Treatment in Covid-19 Patients is Related with Excess Adverse Drug Reactions Without Clinical Benefit. TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.0 .

BAKIR EKİNCİ, P., KARA, E., TELLİ DİZMAN, G., SÖNMEZER, M. Ç., İNKAYA, A. Ç., DEMİRKAN, S. K., ... ÜNAL, S.(2023). Initial Empirical Antibiotic Treatment in Covid-19 Patients is Related with Excess Adverse Drug Reactions Without Clinical Benefit. TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.0.

BAKIR EKİNCİ, PINAR Et Al. "Initial Empirical Antibiotic Treatment in Covid-19 Patients is Related with Excess Adverse Drug Reactions Without Clinical Benefit," TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.0, 2023

BAKIR EKİNCİ, PINAR B. Et Al. "Initial Empirical Antibiotic Treatment in Covid-19 Patients is Related with Excess Adverse Drug Reactions Without Clinical Benefit." TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.0, 2023

BAKIR EKİNCİ, P. Et Al. (2023) . "Initial Empirical Antibiotic Treatment in Covid-19 Patients is Related with Excess Adverse Drug Reactions Without Clinical Benefit." TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.0.

@article{article, author={PINAR BAKIR EKİNCİ Et Al. }, title={Initial Empirical Antibiotic Treatment in Covid-19 Patients is Related with Excess Adverse Drug Reactions Without Clinical Benefit}, journal={TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES}, year=2023}